Advertisement
Screener

NEPHROS, INC. (NEPH) Price / Book

2.8 / 5 stars · 68/120 Roast Me

NEPHROS INC Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • NEPHROS INC price/book ratio for the quarter ending 2023-12-31 was 4.36, a 104.34% increase year-over-year.
  • NEPHROS INC price/book ratio for the quarter ending 2023-09-30 was 1.8, a 20.96% increase year-over-year.
  • NEPHROS INC price/book ratio for the quarter ending 2023-06-30 was 1.88, a 9.67% increase year-over-year.
  • NEPHROS INC price/book ratio for the quarter ending 2023-03-31 was 1.26, a 71.77% decline year-over-year.
  • NEPHROS INC price/book ratio for fiscal 2023 was 4.36, a 104.34% increase from fiscal 2022.
  • NEPHROS INC price/book ratio for fiscal 2022 was 2.14, a 58.73% decline from fiscal 2021.
  • NEPHROS INC price/book ratio for fiscal 2021 was 5.18, a 23.50% decline from fiscal 2020.
  • NEPHROS INC price/book ratio for fiscal 2020 was 6.76, a 60.56% decline from fiscal 2019.
Available history
2010-12-31 to 2023-12-31
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2023-12-314.36$36.48M$8.36M
2023-09-301.8$15.52M$8.62M
2023-06-301.88$16.25M$8.66M
2023-03-311.26$11.22M$8.89M
2022-12-312.14$11.95M$5.59M
2022-09-301.49$9.38M$6.3M
2022-06-301.71$15.79M$9.22M
2022-03-314.47$45.4M$10.16M
2021-12-315.18$60.52M$11.7M
2021-09-307.31$89.74M$12.28M
2021-06-308.58$102.39M$11.94M
2021-03-315.3$66.18M$12.48M
2020-12-316.76$84.71M$12.52M
2020-09-307.79$65.36M$8.39M
2020-06-308.22$75.84M$9.23M
2020-03-315.36$56.8M$10.6M
2019-12-3117.15$80.19M$4.68M
2019-09-3016.88$62.67M$3.71M
2019-06-3011.08$42.12M$3.8M
2019-03-31107.19$279.12M$2.6M
2018-12-319.7$36.86M$3.8M
2018-09-3085.2$346.5M$4.07M
2018-06-3078.32$352.28M$4.5M
2018-03-31113.86$216.1M$1.9M
2017-12-31114.84$223.94M$1.95M
2017-09-30551.82$146.23M$265,000.00
2017-06-30143.18$112.11M$783,000.00
2017-03-31134.81$185.23M$1.37M
2016-12-31248.54$165.78M$667,000.00
2016-09-30134.67$163.89M$1.22M
2016-06-3068.29$114.25M$1.67M
2016-03-3157.33$114.25M$1.99M
2015-12-31-36.11$96.19M-$2.66M
2015-09-3053.7$149.94M$2.79M
2015-06-30-34.73$205.94M-$5.93M
2015-03-31-30.33$164.12M-$5.41M
2014-12-31-38.04$216.08M-$5.68M
2014-09-30-459.19$177.25M-$386,000.00
2014-06-301,240.28$267.9M$216,000.00
2014-03-31189.69$145.3M$766,000.00
2013-12-31-18.38$68.35M-$3.72M
2013-09-30452.96$194.77M$430,000.00
2013-06-30173.21$145.67M$841,000.00
2013-03-31-50.41$85.5M-$1.7M
2012-12-31-215.1$127.98M-$595,000.00
2012-09-30453.6$146.51M$323,000.00
2012-06-30228.44$204.91M$897,000.00
2012-03-3197.28$100.58M$1.03M
2011-12-3145.89$65.21M$1.42M
2011-09-3092.88$172.11M$1.85M
2011-06-3030.49$67.94M$2.23M
2010-12-31278.74$37.63M$135,000.00

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2023-12-314.36$36.48M$8.36M
2022-12-312.14$11.95M$5.59M
2021-12-315.18$60.52M$11.7M
2020-12-316.76$84.71M$12.52M
2019-12-3117.15$80.19M$4.68M
2018-12-319.7$36.86M$3.8M
2017-12-31114.84$223.94M$1.95M
2016-12-31248.54$165.78M$667,000.00
2015-12-31-36.11$96.19M-$2.66M
2014-12-31-38.04$216.08M-$5.68M
2013-12-31-18.38$68.35M-$3.72M
2012-12-31-215.1$127.98M-$595,000.00
2011-12-3145.89$65.21M$1.42M
2010-12-31278.74$37.63M$135,000.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
TELA Bio, Inc. (TELA)United States$0.057B-0.82
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
DarioHealth Corp. (DRIO)$0.066B-1.39